Ely Benaim
Plus aucun poste en cours
Fortune : 449 675 $ au 31/03/2024
Profil
Ely Benaim est médecin en chef chez NovoCure Ltd. Dans le passé, le Dr Benaim a occupé les postes de vice-président des affaires cliniques chez Sangamo Therapeutics, Inc, de directeur médical et de vice-président des affaires réglementaires chez Berg Pharma LLC, de directeur principal de la recherche clinique chez Millennium Pharmaceuticals, Inc, de directeur médical de Rexahn Pharmaceuticals, Inc, de directeur principal de l'oncologie mondiale chez Salmedix, Inc et de professeur adjoint à l'université du Tennessee. Le Dr Benaim a obtenu un doctorat de l'Université centrale du Venezuela.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVOCURE LTD.
0,03% | 06/01/2023 | 28 770 ( 0,03% ) | 449 675 $ | 31/03/2024 |
Anciens postes connus de Ely Benaim
| Sociétés | Poste | Fin |
|---|---|---|
| NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 17/01/2023 |
| REXAHN PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2019 |
| Berg Pharma LLC | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2010 |
Formation de Ely Benaim
| Central University of Venezuela | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| Berg Pharma LLC |
